FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912275633> ?p ?o ?g. }

• W2912275633 endingPage "594" @default.
• W2912275633 startingPage "594" @default.
• W2912275633 abstract "The 18 kDa Translocator Protein (TSPO) is a marker for microglial activation as its expression is enhanced in activated microglia during neuroinflammation. TSPO ligands can attenuate neuroinflammation and neurotoxicity. In the present study, we examined the efficacy of new TSPO ligands designed by our laboratory, MGV-1 and 2-Cl-MGV-1, in mitigating an in vitro neuroinflammatory process compared to the classic TSPO ligand, PK 11195. We exposed BV-2 microglial cells to lipopolysaccharide (LPS) for 24 h to induce inflammatory response and added the three TSPO ligands: (1) one hour before LPS treatment (pretreatment), (2) simultaneously with LPS (cotreatment), and (3) one hour after LPS exposure (post-treatment). We evaluated the capability of TSPO ligands to reduce the levels of three glial inflammatory markers: cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and nitric oxide (NO). We compared the effects of the two novel ligands to PK 11195. Both 2-Cl-MGV-1 and MGV-1 reduced the levels of glial COX-2, iNOS, and NO in LPS-treated BV-2 cells more efficiently than PK 11195. Notably, even when added after exposure to LPS, all ligands were able to suppress the inflammatory response. Due to their pronounced anti-inflammatory activity, 2-Cl-MGV-1 and MGV-1 may serve as potential therapeutics in neuroinflammatory and neurodegenerative diseases." @default.
• W2912275633 created "2019-02-21" @default.
• W2912275633 creator A5022026034 @default.
• W2912275633 creator A5025053584 @default.
• W2912275633 creator A5056842335 @default.
• W2912275633 creator A5063898483 @default.
• W2912275633 creator A5065136701 @default.
• W2912275633 date "2019-01-30" @default.
• W2912275633 modified "2023-10-14" @default.
• W2912275633 title "The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS" @default.
• W2912275633 cites W1505877076 @default.
• W2912275633 cites W1525161181 @default.
• W2912275633 cites W1574200406 @default.
• W2912275633 cites W1596638623 @default.
• W2912275633 cites W1970399739 @default.
• W2912275633 cites W1977642991 @default.
• W2912275633 cites W1987834950 @default.
• W2912275633 cites W1993305977 @default.
• W2912275633 cites W1993466811 @default.
• W2912275633 cites W1996966804 @default.
• W2912275633 cites W2010532641 @default.
• W2912275633 cites W2011114363 @default.
• W2912275633 cites W2011577075 @default.
• W2912275633 cites W2012238314 @default.
• W2912275633 cites W2013196396 @default.
• W2912275633 cites W2019706623 @default.
• W2912275633 cites W2021356347 @default.
• W2912275633 cites W2025473495 @default.
• W2912275633 cites W2025681964 @default.
• W2912275633 cites W2028870346 @default.
• W2912275633 cites W2031299209 @default.
• W2912275633 cites W2032710318 @default.
• W2912275633 cites W2034450620 @default.
• W2912275633 cites W2038663745 @default.
• W2912275633 cites W2038768395 @default.
• W2912275633 cites W2045145531 @default.
• W2912275633 cites W2045415882 @default.
• W2912275633 cites W2055699536 @default.
• W2912275633 cites W2056260636 @default.
• W2912275633 cites W2061673947 @default.
• W2912275633 cites W2065894198 @default.
• W2912275633 cites W2067897311 @default.
• W2912275633 cites W2069181994 @default.
• W2912275633 cites W2069893872 @default.
• W2912275633 cites W2088330312 @default.
• W2912275633 cites W2088393628 @default.
• W2912275633 cites W2100011299 @default.
• W2912275633 cites W2101243397 @default.
• W2912275633 cites W2123422742 @default.
• W2912275633 cites W2128635872 @default.
• W2912275633 cites W2129134080 @default.
• W2912275633 cites W2134107644 @default.
• W2912275633 cites W2135567003 @default.
• W2912275633 cites W2145493299 @default.
• W2912275633 cites W2147920508 @default.
• W2912275633 cites W2154887510 @default.
• W2912275633 cites W2159239201 @default.
• W2912275633 cites W2162535661 @default.
• W2912275633 cites W2165380579 @default.
• W2912275633 cites W2168896993 @default.
• W2912275633 cites W2339753304 @default.
• W2912275633 cites W2343003880 @default.
• W2912275633 cites W2428080562 @default.
• W2912275633 cites W2526584921 @default.
• W2912275633 cites W2563963032 @default.
• W2912275633 cites W2651656482 @default.
• W2912275633 cites W2725377723 @default.
• W2912275633 cites W2771401577 @default.
• W2912275633 cites W3200510216 @default.
• W2912275633 cites W333643404 @default.
• W2912275633 cites W4293247451 @default.
• W2912275633 doi "https://doi.org/10.3390/ijms20030594" @default.
• W2912275633 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6387401" @default.
• W2912275633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30704062" @default.
• W2912275633 hasPublicationYear "2019" @default.
• W2912275633 type Work @default.
• W2912275633 sameAs 2912275633 @default.
• W2912275633 citedByCount "27" @default.
• W2912275633 countsByYear W29122756332019 @default.
• W2912275633 countsByYear W29122756332020 @default.
• W2912275633 countsByYear W29122756332021 @default.
• W2912275633 countsByYear W29122756332022 @default.
• W2912275633 countsByYear W29122756332023 @default.
• W2912275633 crossrefType "journal-article" @default.
• W2912275633 hasAuthorship W2912275633A5022026034 @default.
• W2912275633 hasAuthorship W2912275633A5025053584 @default.
• W2912275633 hasAuthorship W2912275633A5056842335 @default.
• W2912275633 hasAuthorship W2912275633A5063898483 @default.
• W2912275633 hasAuthorship W2912275633A5065136701 @default.
• W2912275633 hasBestOaLocation W29122756331 @default.
• W2912275633 hasConcept C116569031 @default.
• W2912275633 hasConcept C170493617 @default.
• W2912275633 hasConcept C178790620 @default.
• W2912275633 hasConcept C185592680 @default.
• W2912275633 hasConcept C203014093 @default.
• W2912275633 hasConcept C2776791281 @default.
• W2912275633 hasConcept C2776914184 @default.
• W2912275633 hasConcept C2777622882 @default.

• next